PDF herunterladen
Open Access
CC BY 4.0 · Rev Bras Ortop (Sao Paulo) 2025; 60(03): s00451810033
DOI: 10.1055/s-0045-1810033
Artigo Original

Níveis altos de marcadores inflamatórios sistêmicos associados à incidência de metástase em osteossarcoma

High Levels of Systemic Inflammatory Markers Associated with Metastasis Incidence in Osteosarcoma

Authors

  • I. Gede Eka Wiratnaya 

    1   Departamento de Ortopedia e Traumatologia, Faculdade de Medicina, Udayana University, Prof. Ngoerah General Hospital, Bali, Indonésia

  • Mohamad Dimas Ismail

    1   Departamento de Ortopedia e Traumatologia, Faculdade de Medicina, Udayana University, Prof. Ngoerah General Hospital, Bali, Indonésia

  • Risang Haryo Raditya

    1   Departamento de Ortopedia e Traumatologia, Faculdade de Medicina, Udayana University, Prof. Ngoerah General Hospital, Bali, Indonésia

  • I. Putu Dema Prasetya

    1   Departamento de Ortopedia e Traumatologia, Faculdade de Medicina, Udayana University, Prof. Ngoerah General Hospital, Bali, Indonésia

Suporte Financeiro Os autores declaram que não receberam suporte financeiro de agências dos setores público, privado ou sem fins lucrativos para a realização deste estudo.
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints
Preview

Resumo

Objetivo

Este estudo explora a associação entre esses marcadores inflamatórios e metástase em pacientes com osteossarcoma.

Métodos

Realizamos uma análise retrospectiva de pacientes com osteossarcoma de nosso centro entre janeiro de 2022 e agosto de 2024. Coletamos dados clínicos e laboratoriais dos pacientes, incluindo contagem diferencial de leucócitos, níveis de proteína C reativa (PCR), velocidade de hemossedimentação (VHS), razão neutrófilo-linfócito (RNL) e concentrações de fosfatase alcalina (FA) e lactato desidrogenase (LDH). A correlação estatística entre esses marcadores e metástase foi avaliada por meio dos teste do Qui-quadrado de Pearson, exato de Fisher e regressão logística.

Resultados

O estudo incluiu 40 pacientes com osteossarcoma. Níveis altos de contagem de neutrófilos (p = 0,024; razão de chances [RC] = 12,667; IC95% = 1,402–114,419) de PCR (p < 0,001; RC = 17,000; IC95% = 3,464–83,436), VHS (p = 0,009; RC = 19,000; IC95% = 2,119–170,383), RNL (p = 0,006; RC = 7,429; IC95% = 1,778–31,040) e LDH (p = 0,009; RC = 9,333; IC95% = 2,180–39,962) foram significativamente associados à presença de metástase.

Conclusão

A contagem de neutrófilos, a VHS, a RNL e os níveis de PCR e LDH estão significativamente associados à metástase em osteossarcoma, e podem ser marcadores prognósticos valiosos. Pesquisas futuras devem se concentrar em elucidar os mecanismos subjacentes a essa relação e explorar intervenções terapêuticas direcionadas à inflamação para mitigar a metástase.

Abstract

Objective

The present study explores the association between these inflammatory markers and metastasis in osteosarcoma patients.

Methods

We conducted a retrospective analysis of osteosarcoma patients at our center between January 2022 and August 2024. We collected the clinical and laboratory data of the patients, including white blood cell differential count, C-reactive protein (CRP) levels, erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) levels. Statistical correlation between these markers and metastasis was assessed using the Pearson's Chi-squared test, the Fisher's exact test, and logistic regression.

Results

A total of 40 osteosarcoma patients were included. Elevated levels of neutrophil count (p = 0.024; odds ratio [OR] = 12.667; 95%CI = 1.402–114.419), CRP (p < 0.001; OR = 17.000; 95%CI = 3.464–83.436), ESR (p = 0.009; OR = 19.000; 95%CI = 2.119–170.383), NLR (p = 0.006; OR = 7.429; 95%CI = 1.778–31.040), and LDH (p = 0.009; OR = 9.333; 95%CI = 2.180–39.962) were significantly associated with the presence of metastasis.

Conclusion

The neutrophil count, ESR, NLR, and the levels of CRP and LDH are significantly associated with metastasis in osteosarcoma, and they may serve as valuable prognostic markers. Future research should focus on elucidating the mechanisms underlying this relationship and exploring therapeutic interventions targeting inflammation to mitigate metastasis.

Palavras-chave

L-lactato desidrogenase - neoplasias ósseas - osteossarcoma - proteína C-reativa - sedimentação sanguínea

Keywords

blood sedimentation - bone neoplasms - C-reactive protein - L-lactate dehydrogenase - osteosarcoma

Contribuições dos Autores

Todos os colaboradores trabalharam de forma significativa no desenvolvimento do manuscrito e em sua revisão minuciosa antes de sua submissão. IGEW foi responsável pela concepção deste estudo. MDI foi responsável pela redação da primeira versão do documento. RHR e IPDP fizeram contribuições notáveis para a formatação e o refinamento do manuscrito. Por fim, IGEW realizou uma revisão crítica para assegurar o rigor intelectual e foi responsável pela revisão final do artigo.


Trabalho desenvolvido no Departamento de Ortopedia e Traumatologia, Faculdade de Medicina da Universidade Udayana, Hospital Geral Prof. Ngoerah, Bali, Indonésia.




Publikationsverlauf

Eingereicht: 04. Dezember 2024

Angenommen: 22. Mai 2025

Artikel online veröffentlicht:
08. September 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
I. Gede Eka Wiratnaya, Mohamad Dimas Ismail, Risang Haryo Raditya, I. Putu Dema Prasetya. Níveis altos de marcadores inflamatórios sistêmicos associados à incidência de metástase em osteossarcoma. Rev Bras Ortop (Sao Paulo) 2025; 60: s00451810033.
DOI: 10.1055/s-0045-1810033
 

  • Referências

  • 1 Sheng G, Gao Y, Yang Y, Wu H. Osteosarcoma and Metastasis. Front Oncol 2021; 11: 780264
    Suche in Google Scholar
  • 2 Belayneh R, Fourman MS, Bhogal S, Weiss KR. Update on Osteosarcoma. Curr Oncol Rep 2021; 23 (06) 71
    Suche in Google Scholar
  • 3 Roca H, McCauley LK. Inflammation and skeletal metastasis. Bonekey Rep 2015; 4: 706
    Suche in Google Scholar
  • 4 Khandia R, Munjal A. Interplay between inflammation and cancer. Adv Protein Chem Struct Biol 2020; 119: 199-245
    Suche in Google Scholar
  • 5 Ravindranathan D, Master VA, Bilen MA. Inflammatory markers in cancer immunotherapy. Biology (Basel) 2021; 10 (04) 325
    Suche in Google Scholar
  • 6 Pan Y, Lou Y, Wang L. Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2021; 100 (46) e27783
    Suche in Google Scholar
  • 7 Tekneci AK, Akçam Tİ, Kavurmacı Ö. et al. Relationship between survival and erythrocyte sedimentation rate in patients operated for lung cancer. Turk Gogus Kalp Damar Cerrahisi Derg 2022; 30 (03) 381-388
    Suche in Google Scholar
  • 8 Zhang Y, Sun Y, Zhang Q. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int 2020; 20: 224
    Suche in Google Scholar
  • 9 Nakamura T, Grimer RJ, Gaston CL, Watanuki M, Sudo A, Jeys L. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone. Bone Joint J 2013; 95-B (03) 411-418
    Suche in Google Scholar
  • 10 Yang S, Wu C, Wang L, Shan D, Chen B. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients. Int J Clin Exp Pathol 2020; 13 (03) 515-524
    Suche in Google Scholar
  • 11 Kamal AF, Abubakar I, Salamah T. Alkaline phosphatase, lactic dehidrogenase, inflammatory variables and apparent diffusion coefficients from MRI for prediction of chemotherapy response in osteosarcoma. A cross sectional study. Ann Med Surg (Lond) 2021; 64: 102228
    Suche in Google Scholar
  • 12 Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov 2022; 12 (01) 31-46
    Suche in Google Scholar
  • 13 Cersosimo F, Lonardi S, Bernardini G. et al. Tumor-associated macrophages in osteosarcoma: From mechanisms to therapy. Int J Mol Sci 2020; 21 (15) 5027
    Suche in Google Scholar
  • 14 Nirala BK, Yamamichi T, Petrescu DI, Shafin TN, Yustein JT. Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis. Cancers (Basel) 2023; 15 (20) 5108
    Suche in Google Scholar
  • 15 Huang Q, Liang X, Ren T. et al. The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications. Cell Oncol 2021; 44 (03) 525-539
    Suche in Google Scholar
  • 16 Ramanujan V, Krishnamurthy A, Venkataramani K, Kumar C. Pulmonary metastasectomy in primary extremity osteosarcoma: Choosing wisely, along with a brief review of literature. Indian J Cancer 2020; 57 (02) 172-181
    Suche in Google Scholar
  • 17 Hart PC, Rajab IM, Alebraheem M, Potempa LA. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front Immunol 2020; 11: 595835
    Suche in Google Scholar
  • 18 Song X, Zhang H, Yin F. et al. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis. Mediators Inflamm 2021; 2021: 3456629
    Suche in Google Scholar
  • 19 Errani C, Cosentino M, Ciani G. et al C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases. Int Orthop 2021; 45 (05) 1337-1346
    Suche in Google Scholar
  • 20 Liao DW, Hu X, Wang Y, Yang ZQ, Li X. C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis. Ann Clin Lab Sci 2020; 50 (02) 161-171
    Suche in Google Scholar
  • 21 Feng X, Meng M, Li H. et al. T-cell dysfunction in natural killer/T-cell lymphoma. OncoImmunology 2023; 12 (01) 2212532
    Suche in Google Scholar
  • 22 Isaksson J, Wennström L, Branden E. et al. Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer. Cancer Treat Res Commun 2022; 31: 100556
    Suche in Google Scholar
  • 23 Synakiewicz A, Stanislawska-Sachadyn A, Owczarzak A, Skuza M, Stachowicz-Stencel T. Cytokine IL6, but not IL-1β, TNF-α and NF-κB is increased in paediatric cancer patients. Acta Biochim Pol 2023; 70 (02) 395-400
    Suche in Google Scholar
  • 24 Naszai M, Kurjan A, Maughan TS. The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis. Cancer Med 2021; 10 (17) 5983-5997
    Suche in Google Scholar
  • 25 Mukaida N, Sasaki SI, Baba T. Two-faced roles of tumor-associated neutrophils in cancer development and progression. Int J Mol Sci 2020; 21 (10) 3457
    Suche in Google Scholar
  • 26 Forkasiewicz A, Dorociak M, Stach K, Szelachowski P, Tabola R, Augoff K. The usefulness of lactate dehydrogenase measurements in current oncological practice. Cell Mol Biol Lett 2020; 25: 35
    Suche in Google Scholar
  • 27 Le A. , editor. The Heterogeneity of Cancer Metabolism [Internet]. 2nd edition. Cham, Switzerland: Springer; 2021. . Advances in Experimental Medicine and Biology, v. 1,311. Available from: https://www.ncbi.nlm.nih.gov/books/NBK573689/
    Suche in Google Scholar
  • 28 Pérez-Tomás R, Pérez-Guillén I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers (Basel) 2020; 12 (11) 3244
    Suche in Google Scholar